Archive for October 2022
Collagen Matrix Acquires Polyganics
The Investment Expands CMI’s Regenerative Medicine Portfolio, R&D Capabilities and International Manufacturing Operations Oakland, N.J., October 5, 2022 – Collagen Matrix, Inc. (“Collagen Matrix”), a global leader in regenerative medicine and a Linden Capital Partners (“Linden”) portfolio company, today announced the acquisition of Polyganics, B.V (“Polyganics”). Polyganics is a medical technology company that develops and…
Read More